Novartis completes 77% majority ownership of Alcon adding new growth platform in eye care to its leading healthcare portfolio

Basel, August 26, 2010 - Novartis announced today that it has completed its purchase of Alcon stock from Nestlé resulting in 77% ownership of Alcon. This has been achieved by completing the acquisition of the remaining 52% of Alcon shares owned by Nestlé for a total of USD 28.3 billion.

Visit the event center

Read the media release (130 KB)

Watch the webcast